Literature DB >> 2257202

An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease.

E H Cooper1, M A Forbes, M Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2257202      PMCID： PMC1971573          DOI： 10.1038/bjc.1990.426

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  [Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons].

Authors:  I Sakurabayashi; T Yamada; T Kawai; T Yamanaka
Journal:  Rinsho Byori       Date:  1986-06

2.  DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.

Authors:  D M Mahvi; H F Seigler; W C Meyers; H Kalthoff; W H Schmiegel; R S Metzgar
Journal:  Pancreas       Date:  1988       Impact factor: 3.327

3.  [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].

Authors:  Y Takemori; N Sawabu; Y Satomura; H Ohta; H Watanabe; T Okai; M Mai; N Hattori; T Akiyama; T Hashimoto
Journal:  Gan To Kagaku Ryoho       Date:  1987-01

4.  Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

Authors:  H Jalanko; P Kuusela; P Roberts; P Sipponen; C A Haglund; O Mäkelä
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

5.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.

Authors:  J L Magnani; Z Steplewski; H Koprowski; V Ginsburg
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

6.  Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.

Authors:  R S Metzgar; N Rodriguez; O J Finn; M S Lan; V N Daasch; P D Fernsten; W C Meyers; W F Sindelar; R S Sandler; H F Seigler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.

Authors:  N Sawabu; D Toya; Y Takemori; N Hattori; M Fukui
Journal:  Int J Cancer       Date:  1986-05-15       Impact factor: 7.396

8.  Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

Authors:  R S Metzgar; M T Gaillard; S J Levine; F L Tuck; E H Bossen; M J Borowitz
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

9.  Serum levels of cancer-associated antigen CA-195 in gastrointestinal cancers and its comparison with CA19-9.

Authors:  A K Bhargava; N J Petrelli; A Karna; P L Parshall; J E Fitzpatrick; H O Douglass; L Herrera; K Bray; P Gaur
Journal:  J Clin Lab Anal       Date:  1989       Impact factor: 2.352
  9 in total
  3 in total

1.  Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.

Authors:  S Kawa; H Oguchi; T Kobayashi; M Tokoo; S Furuta; M Kanai; T Homma
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

Review 2.  Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

Authors:  Ryan L Hanson; Michael A Hollingsworth
Journal:  Biomolecules       Date:  2016-07-30

Review 3.  Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

Authors:  Robert S O'Neill; Alina Stoita
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.